Filing Flows › Bio-Rad Laboratories (BIO) › Q3 2025
Bio-Rad Laboratories (BIO) Q3 2025 earnings results (third quarter 2025)
10-Q filed Oct 29, 2025
Bio-Rad Laboratories (BIO) reported revenue of $653M for the third quarter 2025 (Q3 2025), +0.5% from a year earlier and +0.2% from the quarter before. Operating margin was 10.0%, net loss $342M (52.4% of revenue).
Bio-Rad Laboratories, Q3 2025: revenue $653M (+0.5% year over year), operating margin 10.0%, net loss $342M, operating cash flow $121M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $653M | +0.2% | +0.5% |
| Operating profit | $65.3M | -15% | — |
| Net earnings | −$342M | -208% | — |
| Operating cash flow | $121M | +4% | -26% |
| Free cash flow | $89.2M | +26% | -28% |
What changed
Revenue was $653.0M in Q3 2025, up 1% year over year and roughly flat from the previous quarter. Clinical Diagnostics was the largest line at 60% of revenue. Clinical Diagnostics added $2.4M year over year (up 1%), 73% of the total change.
Gross margin was 52.6%, down 2.2 points from a year earlier. Operating profit was $65.3M, a 10.0% margin (up 0.1 points year over year). Of the extra revenue versus a year earlier, 24% reached operating profit, above the 10% margin then. Operating expenses fell 5% while revenue rose 1%. The quarter ended with a net loss of $341.9M, after a profit of $317.8M the previous quarter. Net interest and other expense of $496.4M was the main reason.
Operating cash flow was $120.9M (down 26% year over year). Non-cash charges added back $14.9M of share-based compensation. Working capital and other items added $447.9M. Capital expenditures of $31.7M left free cash flow of $89.2M.
Questions
What was Bio-Rad Laboratories' revenue in the third quarter 2025?
Bio-Rad Laboratories (BIO) reported revenue of $653M for the third quarter 2025 (Q3 2025), +0.5% from a year earlier and +0.2% from the quarter before.
Was Bio-Rad Laboratories profitable in the third quarter 2025?
Operating profit was $65.3M (10.0% of revenue) and net loss $342M.